Page last updated: 2024-08-26

nicotine and rivastigmine

nicotine has been researched along with rivastigmine in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (66.67)	29.6817
2010's	4 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Bellman, K; Knegtel, RM; Settimo, L	1
Adam, BL; Gao, J; Terry, AV	1
Caricati-Neto, A; D'angelo, LC; Garcia, AG; Hyppolito Jurkiewicz, N; Jurkiewicz, A; Reuter, H	1
Bermudez, I; Groot-Kormelink, PJ; Smulders, CJ; van Kleef, RG; Vijverberg, HP; Zwart, R	1
Arias, E; Gallego-Sandín, S; García, AG; López, MG; Villarroya, M	1
Aasen, I; Kumari, V; Reed, C; Sharma, T	1
Almkvist, O; Darreh-Shori, T; Kadir, A; Långström, B; Nordberg, A; Wall, A	1
Balogh, R; Berkó, S; Budai-Szűcs, M; Csányi, E; Sinkó, B; Takács-Novák, K; Tóth, G; Vizserálek, G	1
Bazan, R; Bazan, SG; Braga, GP; El Dib, R; Luvizutto, GJ; Resende, LA	1

Reviews

1 review(s) available for nicotine and rivastigmine

Article	Year
Pharmacological interventions for unilateral spatial neglect after stroke. The Cochrane database of systematic reviews, 2015, Nov-06, Issue:11 Topics: Administration, Cutaneous; Humans; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Perceptual Disorders; Randomized Controlled Trials as Topic; Rivastigmine; Stroke; Stroke Rehabilitation	2015

Trials

2 trial(s) available for nicotine and rivastigmine

Article	Year
Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation. Schizophrenia research, 2006, Volume: 85, Issue:1-3 Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Phenylcarbamates; Physostigmine; Psychomotor Performance; Rivastigmine; Schizophrenia; Severity of Illness Index; Verbal Behavior	2006
Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET. Psychopharmacology, 2007, Volume: 191, Issue:4 Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Brain; Butyrylcholinesterase; Carbon Radioisotopes; Cholinesterase Inhibitors; Cognition; Female; Humans; Male; Nicotine; Phenylcarbamates; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Nicotinic; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Outcome	2007

Article

Year

Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation.

Schizophrenia research, 2006, Volume: 85, Issue:1-3

Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Phenylcarbamates; Physostigmine; Psychomotor Performance; Rivastigmine; Schizophrenia; Severity of Illness Index; Verbal Behavior

2006

Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.

Psychopharmacology, 2007, Volume: 191, Issue:4

Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Brain; Butyrylcholinesterase; Carbon Radioisotopes; Cholinesterase Inhibitors; Cognition; Female; Humans; Male; Nicotine; Phenylcarbamates; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Nicotinic; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Outcome

2007

Other Studies

9 other study(ies) available for nicotine and rivastigmine

Article	Year
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease. Bioorganic & medicinal chemistry letters, 2014, Mar-15, Volume: 24, Issue:6 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Cotinine; Humans; Neurons; Neuroprotective Agents; Nicotine; Peptide Fragments; Rats; Receptors, N-Methyl-D-Aspartate	2014
Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens. European journal of pharmacology, 2004, Oct-25, Volume: 503, Issue:1-3 Topics: Acetylcholine; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Donepezil; Drug Synergism; Electric Stimulation; Galantamine; In Vitro Techniques; Indans; Male; Muscle Contraction; Muscle, Smooth; Nicotine; Nicotinic Agonists; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Wistar; Receptors, Purinergic; Rivastigmine; Stimulation, Chemical; Synaptic Transmission; Tacrine; Vas Deferens	2004
Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism. European journal of pharmacology, 2005, Feb-21, Volume: 509, Issue:2-3 Topics: Acetylcholine; Alkaloids; Animals; Atropine; Azocines; Binding, Competitive; Cholinergic Agents; Cholinesterase Inhibitors; Dichlorvos; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Membrane Potentials; Models, Biological; Nicotine; Oocytes; Phenylcarbamates; Physostigmine; Plasmids; Quinolizines; Receptors, Nicotinic; Rivastigmine; Scopolamine; Tacrine; Xenopus laevis	2005
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:3 Topics: Aconitine; Amyloid beta-Peptides; Apoptosis; Benzopyrans; Cell Culture Techniques; Cell Line, Tumor; Cholinesterase Inhibitors; Chromones; Donepezil; Dose-Response Relationship, Drug; Enzyme Inhibitors; Galantamine; Humans; Indans; L-Lactate Dehydrogenase; Morpholines; Neuroblastoma; Neuroprotective Agents; Nicotine; Nitriles; Okadaic Acid; Phenylcarbamates; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-bcl-2; Receptors, Nicotinic; Rivastigmine	2005
Permeability test for transdermal and local therapeutic patches using Skin PAMPA method. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2015, Aug-30, Volume: 76 Topics: Administration, Cutaneous; Chemistry, Pharmaceutical; Fentanyl; Humans; In Vitro Techniques; Ketoprofen; Kinetics; Membranes, Artificial; Models, Biological; Nicotine; Permeability; Rivastigmine; Skin; Skin Absorption; Solubility; Technology, Pharmaceutical; Transdermal Patch	2015